BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:26 pm Sale | 2024-09-30 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -24,435,632 (Position Closed) | Filing |
| 2024-02-14 09:37 am Purchase | 2023-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 24,435,632 9.980% | 8,286,453 (+51.31%) | Filing |
| 2023-02-13 6:20 pm Purchase | 2022-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 16,149,179 8.600% | 1,789,179 (+12.46%) | Filing |
| 2022-02-11 8:33 pm Purchase | 2021-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 14,360,000 9.600% | 3,397,000 (+30.99%) | Filing |
| 2020-12-21 4:37 pm Purchase | 2020-12-11 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 10,963,000 7.800% | 10,963,000 (New Position) | Filing |